Pde8bTg(Alb-NAT2)1Kss
Transgenic Allele Detail
|
Symbol: |
Pde8bTg(Alb-NAT2)1Kss |
Name: |
phosphodiesterase 8B; transgene insertion 1, Kim Sugamori |
MGI ID: |
MGI:6391177 |
Synonyms: |
hNAT2tg |
Gene: |
Pde8b Location: Chr13:95160962-95386844 bp, - strand Genetic Position: Chr13, 49.22 cM
|
Alliance: |
Pde8bTg(Alb-NAT2)1Kss page
|
|
Strain of Origin: |
(C57BL/6 x SJL)F2
|
|
Transgene Type: |
|
Transgenic (Humanized sequence, Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Pde8bTg(Alb-NAT2)1Kss expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
NAT2 (10) |
|
|
|
|
|
Mutation details: The human NAT2 reference wild-type (NAT2*4) gene is under the control of an approximate 2.3-kb mouse albumin enhancer/promoter. The transgene inserted in intron 3 of the mouse Pde8b gene. A recombination event during insertion caused transposition of most of the albumin enhancer region to the 3 end of the transgene construct, but does not markedly impair expression of the human transcript in the liver. Real-time qPCR indicates that transgenic mice have an approximate 40-55% decrease in Pde8b expression in the brain. Real-time qPCR also indicates that the human transcript is detected in the liver and is 2-fold higher in male liver than in female liver and Western blot analysis confirmed expression, with higher level of protein in the male liver than female liver. This line contains a single copy of the transgene.
(J:284698)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Pde8b Mutation: |
57 strains or lines available
|
|
Original: |
J:284698 Sugamori KS, et al., Liver-selective expression of human arylamine N-acetyltransferase NAT2 in transgenic mice. Drug Metab Dispos. 2011 May;39(5):882-90 |
All: |
1 reference(s) |
|